Literature DB >> 35281164

Basaloid squamous cell carcinoma.

V Jai Santhosh Manikandan1, P Sai Krishna1, L S Makesh Raj1, Prasanna Sekhar1.   

Abstract

Basaloid squamous cell carcinoma (BSCC) is a rare variant of squamous cell carcinoma characterized by a conglomerate of clinically aggressive course and disparate histopathological features. It is frequently seen in upper aerodigestive tract area. Histopathologically, it is biphasic and composed of two types of tumor cells, namely basaloid and squamous cells. Tumor markers, namely, BerEp4, epithelial membrane antigen and p53 are used in this case to differentiate from similar tumors which impersonate BSCC histologically but differ prognostically. We report a case of BSCC in a 48-year-old female patient, involving the lateral border of the tongue with an exhaustive picture of its histological and immunohistochemical appearance. Copyright:
© 2022 Journal of Oral and Maxillofacial Pathology.

Entities:  

Keywords:  Basaloid squamous cell carcinoma; BerEp4; epithelial membrane antigen; oral cavity; oropharynx; p53; squamous cell carcinoma

Year:  2022        PMID: 35281164      PMCID: PMC8859593          DOI: 10.4103/jomfp.jomfp_382_21

Source DB:  PubMed          Journal:  J Oral Maxillofac Pathol        ISSN: 0973-029X


INTRODUCTION

Basaloid squamous cell carcinoma (BSCC) is an aggressive and histologically distinct variant of squamous cell carcinoma, first described by Wain et al. in 1986.[1] It has a predilection for upper aerodigestive tract. It is rarely seen in oral cavity with predilection for base of the tongue.[2] It commonly affects males usually above sixth decade.[3] It is considered to be more aggressive when compared to classical squamous cell carcinoma, due to its frequent metastasis.[4] The presence of ulceration makes it difficult to diagnose histopathologically, as it might mask the origin from the superficial mucosa. In the above scenario, it is prudent to use the immunohistochemistry markers which can help us in supporting the diagnosis. We are present a case of similar situation where three tumor markers are used namely p53, BerEp4 and epithelial membrane antigen (EMA) to establish the diagnosis.[567]

CASE DETAILS

A 48-year-old female patient came with the chief complaint of difficulty in opening the mouth and painful ulcer in the tongue for the past 6 months. Medical history reveals no significant findings. The patient had no history of tobacco habits and was well built. On extraoral examination, submandibular lymph nodes were palpable on the left side which was firm in consistency. On intraoral examination, an ulceroproliferative lesion was found on the left lateral side of the tongue measuring 3 cm × 2 cm, which was firm in consistency with indurated margin.

Microscopic findings

Overlying epithelium showed dysplastic stratified squamous epithelium infiltrating into the underlying connective tissue [Figure 1a]
Figure 1(a-d)

Histopathological image shows overlying dysplastic stratified squamous epithelium infiltrating into the underlying connective in the form of sheets and lobular pattern. Tumor cells show hyperchromatic nuclei, scanty cytoplasm

Two types of tumor cells, namely squamous cells and basaloid cells, are seen [Figure 1b] Tumor cells are characterized by sheets of basaloid cells with hyperchromatic nuclei and scanty cytoplasm predominantly arranged in lobular pattern [Figure 1c and d] Squamous differentiation seen in center of tumor islands [Figure 2a]
Figure 2(a-d)

Histopathological image shows central squamous differentiation, peripheral palisading, increased mitotic activity and skeletal muscle infiltration of tumor cells

Tumor cells show peripheral palisading [Figure 2b], marked mitotic activity [Figure 2c] and skeletal muscle infiltration [Figure 2d]. Histopathological image shows overlying dysplastic stratified squamous epithelium infiltrating into the underlying connective in the form of sheets and lobular pattern. Tumor cells show hyperchromatic nuclei, scanty cytoplasm Histopathological image shows central squamous differentiation, peripheral palisading, increased mitotic activity and skeletal muscle infiltration of tumor cells

Immunohistochemistry findings

Tumor cells stained positive for p53, except in the areas of squamous differentiation in the center of tumor island [Figure 3a-d]
Figure 3(a-d)

Histopathological image shows tumor cells stained positive for p53 except in the areas of squamous differentiation within tumor island

Tumor cells stained negative for BerEp4 [Figure 4a-d].
Figure 4(a-d)

Histopathological image shows tumor cells stained negative for Ber-Ep4

Tumor cells stained positive for EMA, except in the areas of squamous differentiation within tumor island, which stained positive for EMA [Figure 5a-d].
Figure 5(a-d)

Histopathological image shows tumor cells predominantly stained negative for epithelial membrane antigen. Focal positive stain is seen in the areas of squamous differentiation

Histopathological image shows tumor cells stained positive for p53 except in the areas of squamous differentiation within tumor island Histopathological image shows tumor cells stained negative for Ber-Ep4 Histopathological image shows tumor cells predominantly stained negative for epithelial membrane antigen. Focal positive stain is seen in the areas of squamous differentiation Differential diagnosis of BSCC is mentioned in Table 1,[891011121314] Final diagnosis was made BSCC.
Table 1

Differential diagnosis

TumorHistopathology featuresImmunhistochemistry featureOur case
Basosquamous carcinomaBasal cell carcinoma component with basaloid cells showing peripheral palisading, coexisting with squamous cell carcinoma componentBerEp4 – Positive EMA – NegativeBerEp4 – Positive EMA – Negative
Adenoid cystic carcinomaTumor cells do not show marked nuclear atypia and mitotic figures, while hyaline material is extensively seen. Squamous differentiation within tumor islands and/or overlying dysplastic epithelium is usually absentEMA – luminal cells shows positivity
Small cell endocrine carcinomaSmall hyperchromatic cells with scanty cytoplasm, absence of nucleoli and presence of necrosisEMA – PositiveEMA – Negative (except areas of squamous differentiation)
Adenosquamous carcinomaPresence of ductoglandular differentiation and intracellular mucin Absence of basaloid cells with peripheral palisadingp53 – Positivep53 – Positive
Squamous cell carcinomaLacks basaloid cells with increased mitotic activity, peripheral palisading and comedo necrosisBerEp4 – Negative EMA – PositiveBerEp4 – Negative EMA – Negative (except areas of squamous differentiation)

EMA: Epithelial membrane antigen

Differential diagnosis EMA: Epithelial membrane antigen

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  10 in total

Review 1.  Basaloid squamous cell carcinoma of the head and neck: a clinicopathological and follow-up study of 40 cases and review of the literature.

Authors:  Cosme Ereño; Ayman Gaafar; Maddi Garmendia; Carmen Etxezarraga; Francisco J Bilbao; José I López
Journal:  Head Neck Pathol       Date:  2008-03-21

2.  Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.

Authors:  T W Beer; P Shepherd; J M Theaker
Journal:  Histopathology       Date:  2000-09       Impact factor: 5.087

3.  Immunohistochemistry in ocular carcinomas.

Authors:  Brett Sramek; Allison Lisle; Timothy Loy
Journal:  J Cutan Pathol       Date:  2008-01-14       Impact factor: 1.587

4.  Basaloid squamous cell carcinoma of the mandible: report of two cases.

Authors:  Eiji Hirai; Kozo Yamamoto; Noriaki Yamamoto; Yoshihiro Yamashita; Toshiaki Kounoe; Yoshihide Kondo; Hirotoshi Yonemasu; Tetsu Takahashi; Hideo Kurokawa
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-11

5.  Expression of cytokeratin subtypes: MMP-9, p53, and αSMA to differentiate basaloid squamous cell carcinoma from other basaloid tumors of the oral cavity.

Authors:  Deepa R Mane; Alka D Kale; Punnya Angadi; Seema Hallikerimath
Journal:  Appl Immunohistochem Mol Morphol       Date:  2013-10

6.  Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases.

Authors:  S L Wain; R Kier; R T Vollmer; E H Bossen
Journal:  Hum Pathol       Date:  1986-11       Impact factor: 3.466

7.  Adenoid cystic carcinoma of the salivary glands: an immunohistochemical analysis.

Authors:  J C Chen; D R Gnepp; C W Bedrossian
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1988-03

8.  BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia.

Authors:  Katy R Linskey; Devon C Gimbel; Lawrence R Zukerberg; Lyn M Duncan; Peter M Sadow; Rosalynn M Nazarian
Journal:  Arch Pathol Lab Med       Date:  2013-11       Impact factor: 5.534

9.  Small cell neuroendocrine carcinoma of the orbit presenting as an orbital abscess in a young female.

Authors:  Ruchi Mittal; Hrishikesh Kaza; Sunil Agarwal; Suryasnata Rath; Swarnalatha Gowrishankar
Journal:  Saudi J Ophthalmol       Date:  2018-07-27

10.  Clinical and epidemiological analysis of basosquamous carcinoma: results of the multicenter study.

Authors:  Magdalena Ciążyńska; Martyna Sławińska; Grażyna Kamińska-Winciorek; Dariusz Lange; Bogumił Lewandowski; Adam Reich; Marta Pabianek; Katarzyna Szczepaniak; Adam Hankiewicz; Małgorzata Ułańska; Jan Morawiec; Maria Błasińska-Morawiec; Zbigniew Morawiec; Janusz Piekarski; Robert Brodowski; Anna Zaryczańska; Michał Sobjanek; Witold Owczarek; Monika Słowińska; Katarzyna Wróbel; Andrzej Bieniek; Anna Woźniacka; Małgorzata Skibińska; Joanna Narbutt; Wojciech Niemczyk; Karol Ciążyński; Aleksandra Lesiak
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.